The COVID‐19 pandemic has led to significant changes in healthcare systems that impact the management of chronic diseases such as diabetic foot (DF). We hypothesized that lack of access to healthcare would increase the severity of disease and lead to worse outcomes.
Methods
The medical records of patients with DF were reviewed to determine demographic data and outcomes including wound healing, major amputation (MA), and death. Groups were divided into the pre–COVID-19 era (15 March 2019–15 March 2020) and the COVID-19 era (16 March 2020–16 March 2021); multivariable logistic analysis was performed to identify risk factors for MA.
Results
261 patients with DF were included, 163 in the pre–COVID-19 era and 98 during the COVID-19 era. Patients in the COVID-19 presented with increased cardiovascular disease (19 vs 7%, p = 0.01), increased mean HbA1C (9.1 ± 2.1 vs 8.2 ± 2.1, p = 0.008) and higher WIFI-IV stage (78 vs 53%, p ≤ 0.0001). Patients with DF in the COVID-19 era were more likely to require MA (41 vs 21%, p ≤ 0.0001). Revascularization (OR = 0.12; 95% CI, 0.038–0.38) was a protective factor to reduce MA.
Conclusions
MA among DF patients increased two-fold during the COVID-19 era. Revascularization avoids MA in diabetic patients even during the COVID-19 pandemic, suggesting that revascularization should be performed when possible.
DoubovaSVLeslieHHKrukME, et al.Disruption in essential health services in Mexico during COVID-19: an interrupted time series analysis of health information system data. BMJ Glob HealthPMCID2021; 6(9): e006204. DOI: 10.1136/bmjgh-2021-006204.
2.
GerotziafasGTCatalanoMColganM-P, et al.Guidance for the management of patients with vascular disease or cardiovascular risk factors and COVID-19: position paper from VAS-european independent foundation in angiology/vascular medicine. Thromb Haemost2020; 120(12): 1597–1628. DOI: 10.1055/s-0040-1715798.
3.
ConteMSBradburyAWKolhP, et al.Global vascular guidelines on the management of chronic limb-threatening ischemiaEpub 2019 Jun 8. Erratum in. J Vascular surgeryEur J Vasc Endovasc SurgEur J Vasc Endovasc Surg2019; 695960(1S31): 3S492158–e40493159. DOI: 10.1016/j.ejvs.2019.05.006.
4.
MusuuzaJSutherlandBLKurterS, et al.A systematic review of multidisciplinary teams to reduce major amputations for patients with diabetic foot ulcers. J Vasc Surg2020; 71(4): 1433–1446. DOI: 10.1016/j.jvs.2019.08.244.
5.
Moya-JimenezSMorales-OchoaYGSerrano-LozanoJA. Incidence of major amputations secondary to diabetic foot prior and after endovascular revascularization. Rev Mex Angiol2020; 48(1): 11–16.
6.
LancasterEMWuBIannuzziJ, et al.Impact of the coronavirus disease 2019 pandemic on an academic vascular practice and a multidisciplinary limb preservation program. J Vasc Surg2020; 72(6): 1850–1855. DOI: 10.1016/j.jvs.2020.08.132.
7.
CarroGVCarlucciEMTorterolaI, et al.Diabetic foot and COVID-19. medical consultation and severity of lesions compared to 2019. Medicina2020; 80(Suppl 6): 30–34.
8.
SchuivensPMEBuijsMBoonman-de WinterL, et al.Impact of the COVID-19 lockdown strategy on vascular surgery practice: more major amputations than usual. Ann Vasc Surg2020; 69: 74–79. DOI: 10.1016/j.avsg.2020.07.025.
9.
SchaperNCvan NettenJJApelqvistJIWGDF Editorial Board, et al.Practical guidelines on the prevention and management of diabetic foot disease (IWGDF 2019 update). Diabetes/metabolism Research Reviews2020; 36(Suppl 1): e3266. DOI: 10.1002/dmrr.3266. PMID: 32176447.
AhsanTRaniBSiddiquiRS, et al.COVID-19 Infection-related coagulopathy and acute limb ischemia in a patient with pre-existing diabetes. Cureus2021; 13(8): e17531. DOI: 10.7759/cureus.17531.
12.
MillsJLSrConteMSArmstrongDG, et al.The society for vascular surgery lower extremity threatened limb classification system: risk stratification based on wound, ischemia, and foot infection (WIfI). J Vasc Surg2014; 59(1): 220e1–2342. DOI: 10.1016/j.jvs.2013.08.003.
13.
DessieZGZewotirT. Mortality-related risk factors of COVID-19: a systematic review and meta-analysis of 42 studies and 423,117 patients. BMC Infect Dis2021; 21(1): 855. DOI: 10.1186/s12879-021-06536-3.
14.
GiriMPuriAWangT, et al.Clinical features, comorbidities, complications and treatment options in severe and non‐severe COVID‐19 patients: a systemic review and meta‐analysis. Nurs OpenPMCID2021; 8(3): 1077–1088. DOI: 10.1002/nop2.718.
15.
GiorginoFBhanaSCzupryniakL, et al.Management of patients with diabetes and obesity in the COVID-19 era: experiences and learnings from south and east Europe, the middle east, and Africa. Diabetes Res Clin Pract2021; 172: 108617. DOI: 10.1016/j.diabres.2020.108617.
16.
CasciatoDJYancovitzSThompsonJ, et al.Diabetes-related major and minor amputation risk increased during the COVID-19 pandemic. J Am Podiatric Med Assoc2020: 20–224. DOI: 10.7547/20-224.
17.
ViswanathanVNachimuthuS. Major lower-limb amputation during the COVID pandemic in South India. Int J Lower Extremity Wounds2021: 1–5. DOI: 10.1177/15347346211020985.
18.
Urbančič-RovanV. Diabetic foot care before and during the COVID-19 epidemic: what really matters?Diabetes CarePMCID2021; 44(2): e27–e28. DOI: 10.2337/dc20-2650.
19.
RogersLCLaveryLAJosephWS, et al.All feet on deck-the role of podiatry during the COVID-19 pandemic: preventing hospitalizations in an overburdened healthcare system, reducing amputation and death in people with diabetes. J Am Podiatric Med Assoc2020; 1–5. DOI: 10.7547/20-051.
20.
CarusoPLongoMSignorielloS, et al.Diabetic foot problems during the COVID-19 pandemic in a tertiary care center: the emergency among the emergencies. Diabetes Care2020; 43(10): e123–e124. DOI: 10.2337/dc20-1347.
21.
ComaEMoraNMéndezL, et al.Primary care in the time of COVID-19: monitoring the effect of the pandemic and the lockdown measures on 34 quality of care indicators calculated for 288 primary care practices covering about 6 million people in Catalonia. BMC Fam Pract2020; 21(1): 208, DOI: 10.1186/s12875-020-01278-8.
22.
NopsoponTKittrakulratJTakkavatakarnK, et al.Covid-19 in end-stage renal disease patients with renal replacement therapies: a systematic review and meta-analysis. Plos Negl Trop Diseases2021; 15(6): e0009156. DOI: 10.1371/journal.pntd.0009156.
23.
HicksCWZhangGQCannerJK, et al.The global anatomic staging system does not predict limb based patency of tibial endovascular interventions. Ann Vasc Surg2021; 75: 79–85. DOI: 10.1016/j.avsg.2021.04.007.
24.
El KhouryRWuBEdwardsCT, et al.The global limb anatomic staging system is associated with outcomes of infrainguinal revascularization in chronic limb threatening ischemia. J Vasc Surg2021; 73(6): 2009–2020. DOI: 10.1016/j.jvs.2020.12.094.
25.
TaoFTangXTaoH, et al.Surgical treatment of diabetic foot ulcers during the COVID-19 pandemic in China. J Diabetes Its Complications2020; 34(9): 107622. DOI: 10.1016/j.jdiacomp.2020.107622.
26.
NajafiB. Post the pandemic: how will COVID-19 transform diabetic foot disease management?J Diabetes Sci Technol2020; 14(4): 764–766. DOI: 10.1177/1932296820930290. Epub 2020.
27.
SchmidtBMMunsonMERothenbergGM, et al.Strategies to educe severe diabetic foot nfections and complications uring pidemics (STRIDE). J Diabetes Its ComplicationsPMCID2020; 34(11): 107691. DOI: 10.1016/j.jdiacomp.2020.107691.
28.
MannDMChenJChunaraR, et al.COVID-19 transforms health care through telemedicine: evidence from the field. J Am Med Inform Assoc2020; 27(7): 1132–1135. DOI: 10.1093/jamia/ocaa072.
29.
ShinLBowlingFLArmstrongDG, et al.Saving the diabetic foot during the COVID-19 pandemic: a tale of two cities. Diabetes Care2020; 43(8): 1704–1709. DOI: 10.2337/dc20-1176.
30.
ForsytheROApelqvistJBoykoEJ, et al.Effectiveness of revascularisation of the ulcerated foot in patients with diabetes and peripheral artery disease: a systematic review. Diabetes/metabolism Research Reviews2020; 36(Suppl 1): e3279. DOI: 10.1002/dmrr.3279. PMID: 32176439.
31.
LouJ-YKennedyKFMenardMT, et al.North American lower-extremity revascularization and amputation during COVID-19: observations from the vascular quality initiative. Vasc Med2021; 26: 613–623. DOI: 10.1177/1358863X211021918.
32.
BhaskarSRastogiAChattuVK, et al.Key strategies for clinical management and improvement of healthcare services for cardiovascular disease and diabetes patients in the coronavirus (COVID-19) settings: recommendations from the REPROGRAM consortium. Front Cardiovasc Med2020; 7: 112.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
